NCT05617378

Brief Summary

In Pakistan, due to the lack of a National based cancer registry exact number of CRC cases is unknown. However, minimal data that is present in literature shows an increase in CRC cases with a concerning increase in incidence in younger age groups11. This makes it pertinent to understand current pattern of CRC and its risk factors from a local perspective. This will direct future strategies in an attempt to reduce the incidence and mortality associated with CRC in our general population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
558

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2022

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

November 7, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 15, 2022

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

April 22, 2024

Status Verified

April 1, 2024

Enrollment Period

12 months

First QC Date

November 7, 2022

Last Update Submit

April 19, 2024

Conditions

Colorectal CancerColorectal Neoplasms

Keywords

colorectal carcinomaPakistan

Outcome Measures

Primary Outcomes (1)

  • Risk factor

    evaluate internationally validated risk factors for colorectal cancer in our general population using a questionnaire based on the modified Asian Pacific Colorectal Screening score.

    1 year

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

attendants to the patients visiting outpatient department or admitted in hospital.

You may qualify if:

  • Individuals visiting SIUT as attendants to the patients visiting outpatient department or admitted in hospital.

You may not qualify if:

  • Attendants / whose patients visit GI, colon and oncology OPD outpatient department or admitted in GI wards.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sindh Institute of Urology and Transplantation

Karachi, Sindh, Pakistan

Location

MeSH Terms

Conditions

Colorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Study Officials

  • Muhammad Shadab Khan

    Sindh Institute of Urology and Transplantation

    PRINCIPAL INVESTIGATOR

  • Bushra Shirazi

    Sindh Institute of Urology and Transplantation

    STUDY CHAIR

  • Muhammad Arsalan Khan

    Sindh Institute of Urology and Transplantation

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Officer

Study Record Dates

First Submitted

November 7, 2022

First Posted

November 15, 2022

Study Start

November 1, 2022

Primary Completion

October 31, 2023

Study Completion

December 31, 2023

Last Updated

April 22, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations

PA(1)